The SYNE1 gene is associated with a condition known as Spinocerebellar Ataxia Type 8 (SCA8), which is a genetic disorder characterized by progressive problems with movement. This condition primarily affects the cerebellum, the part of the brain that controls coordination and balance. Symptoms of SCA8 may include uncoordinated movements, trouble walking, and issues with speech. It is an autosomal recessive disorder, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the condition.
To diagnose this condition, a specific genetic test is available at DNA Labs UAE, which focuses on identifying mutations in the SYNE1 gene that are responsible for SCA8. The test is crucial for confirming the diagnosis, understanding the risk of passing the condition to the next generation, and guiding management and treatment decisions. The cost of the SYNE1 gene Spinocerebellar Ataxia Type 8 Autosomal Recessive Genetic Test at DNA Labs UAE is 4400 AED. This test is a valuable resource for individuals with a family history of SCA8 or those exhibiting symptoms of the disorder, providing them with critical information about their genetic health.
The COQ8A gene spinocerebellar ataxia type 9 (SCAR9) autosomal recessive genetic test is a specialized diagnostic tool used to identify mutations in the COQ8A gene, which are linked to the development of SCAR9. Spinocerebellar ataxia type 9 is a rare genetic disorder characterized by progressive difficulties with coordination and movement, stemming from degeneration in specific areas of the brain, particularly the cerebellum. The autosomal recessive nature of the condition means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The test involves analyzing the individual's DNA, extracted from a blood sample, to look for specific genetic alterations in the COQ8A gene that are known to cause SCAR9. This genetic testing is crucial for early diagnosis, which can help in managing symptoms, planning for future healthcare needs, and providing information for family planning decisions.
In the United Arab Emirates, this genetic test is available at DNA Labs UAE, a leading provider of genetic testing services. The cost of the COQ8A gene spinocerebellar ataxia type 9 autosomal recessive genetic test at DNA Labs UAE is 4400 AED. This test is a significant resource for families and individuals at risk of SCAR9, offering them a chance to understand their genetic status and make informed decisions about their health and well-being.
The TDP1 Gene Spinocerebellar Ataxia with Axonal Neuropathy Autosomal Recessive Genetic Test is a specialized diagnostic assessment offered by DNA Labs UAE, designed to identify mutations in the TDP1 gene, which are implicated in the development of spinocerebellar ataxia with axonal neuropathy. This condition is a rare, inherited neurological disorder characterized by a progressive loss of muscle coordination (ataxia) and nerve damage (neuropathy), affecting movement and sensory functions. The test is crucial for individuals with a family history of the disorder or those exhibiting symptoms, providing essential information for accurate diagnosis and management. Priced at 4400 AED, this genetic test involves analyzing the patient's DNA to detect specific mutations in the TDP1 gene, helping in confirming the diagnosis and guiding treatment options, while also offering the possibility for family planning and genetic counseling for affected families.
The ATXN10 gene is associated with Spinocerebellar Ataxia Type 10 (SCA10), a disorder characterized by progressive coordination problems due to the degeneration of the cerebellum in the brain. This condition is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder. The ATXN10 gene test is a crucial diagnostic tool for identifying mutations within the ATXN10 gene, helping in the diagnosis of SCA10. This genetic test is available at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the ATXN10 gene test at DNA Labs UAE is 4400 AED. This test can provide individuals and families with essential information regarding the genetic basis of Spinocerebellar Ataxia Type 10, facilitating informed decisions about management and care for affected individuals.
The ANO10 gene is associated with a rare form of Spinocerebellar Ataxia, specifically Type 10 (SCA10), which is an autosomal recessive genetic disorder. This condition is characterized by progressive degeneration of the cerebellum, leading to coordination and balance difficulties, among other symptoms. Given the hereditary nature of SCA10, genetic testing is a crucial tool for diagnosis, family planning, and understanding the risk of transmission to offspring.
DNA Labs UAE offers a comprehensive genetic test targeting the ANO10 gene to identify mutations that cause Spinocerebellar Ataxia Type 10. This test is particularly important for individuals with a family history of SCA10 or those exhibiting symptoms suggestive of the condition. The genetic test is priced at 4400 AED and involves analyzing DNA samples to detect the presence of specific mutations in the ANO10 gene that are known to cause the disorder. By confirming a diagnosis through genetic testing, affected individuals can receive appropriate counseling, consider their options for management and treatment, and make informed decisions about family planning.
The TTBK2 gene plays a crucial role in the development of Spinocerebellar Ataxia Type 11 (SCA11), a condition characterized by progressive coordination problems due to cerebellar ataxia. This condition is inherited in an autosomal dominant manner, meaning only one copy of the altered gene in each cell is sufficient to cause the disorder. As a part of diagnostic measures, genetic testing for mutations in the TTBK2 gene can provide definitive confirmation of SCA11.
At DNA Labs UAE, individuals concerned about their genetic predisposition to SCA11 can undergo a specific genetic test targeting the TTBK2 gene. The cost of this test is set at 4400 AED. This test is crucial for individuals with a family history of SCA11, as it can help in early diagnosis, allowing for timely intervention and management strategies to slow the progression of symptoms. The testing process involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed for mutations in the TTBK2 gene.
The PPP2R2B gene is associated with Spinocerebellar Ataxia Type 12 (SCA12), a rare hereditary disorder characterized by progressive degeneration of the cerebellum, the part of the brain that is responsible for coordinating movement. This condition typically manifests as tremors, unsteady gait, and difficulty with fine motor tasks. SCA12 is an autosomal dominant condition, meaning that an individual only needs a single copy of the altered gene from one parent to be affected.
To diagnose this condition, a genetic test targeting the PPP2R2B gene can be conducted. This test looks for specific mutations in the gene that are known to cause SCA12. Identifying these mutations can confirm a diagnosis, help assess the risk of passing the condition to offspring, and aid in the management and treatment of symptoms.
In the United Arab Emirates, DNA Labs UAE offers this specific genetic test. The cost of the test is 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology to provide accurate and reliable genetic testing services. By opting for this test, individuals who have a family history of SCA12 or exhibit symptoms associated with the condition can gain valuable insights into their genetic makeup, enabling informed decisions regarding their health and future.
The "WWOX Gene Spinocerebellar Ataxia Type 12 Autosomal Recessive Genetic Test" is a specialized diagnostic procedure designed to identify mutations in the WWOX gene, which have been linked to Spinocerebellar Ataxia Type 12 (SCA12), an autosomal recessive neurodegenerative disorder. This condition is characterized by progressive coordination problems, difficulty with speech, and tremors due to cerebellar atrophy. The test aims to provide crucial genetic information for affected individuals and their families, facilitating early diagnosis and management of the condition.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test employs advanced genomic technologies to ensure accurate and reliable results. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and expertise required to interpret the genetic data accurately. This test is pivotal for at-risk families, offering insights into genetic predispositions and enabling informed decisions regarding health management and potential treatments.
The KCNC3 gene is associated with a condition known as Spinocerebellar Ataxia Type 13 (SCA13), which is a type of hereditary ataxia. SCA13 is characterized by a progressive degeneration of the cerebellum, the part of the brain that is responsible for coordinating movement. This condition leads to symptoms such as uncoordinated movement, poor balance, and difficulty with speech. SCA13 is inherited in an autosomal dominant manner, meaning that an individual only needs a single copy of the altered gene from one parent to be affected.
A genetic test is available to identify mutations in the KCNC3 gene, which can confirm a diagnosis of SCA13. This test is crucial for individuals with a family history of the condition or those exhibiting symptoms, as it can provide a definitive diagnosis and help guide management and treatment options. Additionally, it can offer information for family planning.
In the UAE, this specific genetic test can be conducted at DNA Labs, a facility known for its comprehensive genetic testing services. The cost of the KCNC3 gene test for Spinocerebellar Ataxia Type 13 at DNA Labs UAE is 4400 AED. This test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect mutations in the KCNC3 gene. The results of this test can provide individuals and families with essential information regarding the diagnosis, prognosis, and inheritance pattern of SCA13, enabling them to make informed decisions about their health and future.
The GRM1 gene, associated with Spinocerebellar Ataxia Type 13 (SCA13), plays a crucial role in the development and function of the cerebellum, which is responsible for coordinating movement. Mutations in this gene can lead to SCA13, a condition characterized by progressive problems with movement, including poor coordination, unsteady walking, and involuntary eye movements. This condition is inherited in an autosomal recessive pattern, meaning that an individual must receive a mutated gene from both parents to be affected.
In the United Arab Emirates, DNA Labs UAE offers a genetic test specifically designed to identify mutations in the GRM1 gene that cause Spinocerebellar Ataxia Type 13. This test is critical for individuals with a family history of the condition or those exhibiting symptoms, as it can provide a definitive diagnosis. The test involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for the presence of mutations in the GRM1 gene.
The cost of the GRM1 gene test at DNA Labs UAE is 4400 AED. This test is an important tool for genetic counseling, helping families understand the risk of passing the condition to future generations. It also assists healthcare professionals in managing and treating the condition more effectively, by tailoring interventions to the specific needs of individuals with SCA13.
